Fotemustine Chemoembolization of Hepatic Metastases From Uveal Melanoma: A Retrospective Single-Center Analysis

Abstract

TACE of hepatic metastasis from uveal melanoma with fotemustine is well tolerated, and the survival rates in this study (mean, 28.7 months) are among the longest reported.